Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling, regenerative medicine, drug discovery, and personalized therapy. By reprogramming somatic cells into a pluripotent state, iPSCs provide a renewable and patient-specific resource for diverse biomedical applications.
I-Link Bio offers industry-leading iPSC generation services with the capacity to process up to 100 samples simultaneously, ensuring efficient support for both large-scale projects and individual research needs. With a >95% success rate, our reprogramming protocols consistently deliver reliable outcomes, saving clients valuable time and resources.
Every iPSC line undergoes rigorous quality control, including marker expression analysis, karyotype stability testing, differentiation potential assessment, and sterility checks. Only lines that meet the highest standards are delivered.
Applications of our iPSC lines span from disease modeling and gene editing to regenerative therapy development and drug screening. Partner with us to accelerate discovery and innovation with confidence.